Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Urohealth Systems

This article was originally published in The Gray Sheet

Executive Summary

Urohealth Systems: Costa Mesa, California-based manufacturer of the Cen-slide system for microscopic urine analysis and the Dristar product for incontinence, completes its stock acquisition of Dacomed Corporation. The deal gives Urohealth, formerly called Davstar Industries, several additional urological products, including the Dura II penile implant, the Rigiscan diagnostic product for rigidity, and the Catalyst vacuum device. Under the deal, Dacomed shareholders were issued 5.2 mil. shares of Urohealth stock. The merger, valued at about $19 mil., is Urohealth's second recent acquisition in the urology area. In another deal that closed near the end of July, the company issued 571,000 shares to acquire Allstate Medical, an incontinence products manufacturer. In separate news, Urohealth says it has issued to FoxMeyer Health Corporation $2.5 mil. in exchangeable convertible preferred stock, and warrants to purchase 2.4 mil. common shares, as FoxMeyer fulfills its commitment to invest $5 mil. in the company...

You may also be interested in...



‘Highly Questionable’ GMP Compliance In Pakistan Prompts New Licensing System

Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.

Infographic: 20 Years Of Mega-Deals

The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019. 

Belgians To Tackle High Benzodiazepine Use

The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications. 

UsernamePublicRestriction

Register

MT004485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel